Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2019 Jul 8;14(7):e0219614. doi: 10.1371/journal.pone.0219614

Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

Paola Anna Jablonska, Ricardo Diez-Valle, Jaime Gállego Pérez-Larraya, Marta Moreno-Jiménez, Miguel Ángel Idoate, Leire Arbea, Sonia Tejada, Maria Reyes Garcia de Eulate, Luis Ramos, Javier Arbizu, Pablo Domínguez, José Javier Aristu
PMCID: PMC6613680  PMID: 31283793

There is an error in the XML of the article. As a result, the third author’s name is listed in the citation incorrectly. The correct citation is: Jablonska PA, Diez-Valle R, Gállego Pérez-Larraya J, Moreno-Jiménez M, Idoate MÁ, Arbea L, et al. (2019) Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS ONE 14(6): e0217881. https://doi.org/10.1371/journal.pone.0217881

Reference

  • 1.Jablonska PA, Diez-Valle R, Pérez-Larraya JG, Moreno-Jiménez M, Idoate MÁ, Arbea L, et al. (2019) Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS ONE 14(6): e0217881 10.1371/journal.pone.0217881 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES